Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $7.34 Million - $8.28 Million
-28,700 Reduced 84.41%
5,300 $1.53 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $2.43 Million - $3.01 Million
11,100 Added 48.47%
34,000 $9.14 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $1.52 Million - $1.8 Million
7,100 Added 44.94%
22,900 $5.08 Million
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $3.43 Million - $4.18 Million
-15,200 Reduced 49.03%
15,800 $3.82 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $7.1 Million - $9.02 Million
31,000 New
31,000 $0

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.